These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31327173)
1. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor. Beetch M; Lubecka K; Shen K; Flower K; Harandi-Zadeh S; Suderman M; Flanagan JM; Stefanska B Mol Nutr Food Res; 2019 Oct; 63(19):e1801386. PubMed ID: 31327173 [TBL] [Abstract][Full Text] [Related]
2. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Lubecka K; Kurzava L; Flower K; Buvala H; Zhang H; Teegarden D; Camarillo I; Suderman M; Kuang S; Andrisani O; Flanagan JM; Stefanska B Carcinogenesis; 2016 Jul; 37(7):656-68. PubMed ID: 27207652 [TBL] [Abstract][Full Text] [Related]
3. Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells. Beetch M; Boycott C; Harandi-Zadeh S; Yang T; Martin BJE; Dixon-McDougall T; Ren K; Gacad A; Dupuis JH; Ullmer M; Lubecka K; Yada RY; Brown CJ; Howe LJ; Stefanska B J Nutr Biochem; 2021 Dec; 98():108815. PubMed ID: 34242723 [TBL] [Abstract][Full Text] [Related]
4. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Shikauchi Y; Saiura A; Kubo T; Niwa Y; Yamamoto J; Murase Y; Yoshikawa H Mol Cell Biol; 2009 Apr; 29(7):1944-58. PubMed ID: 19139273 [TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression. Wang YA; Kamarova Y; Shen KC; Jiang Z; Hahn MJ; Wang Y; Brooks SC Cancer Biol Ther; 2005 Oct; 4(10):1138-43. PubMed ID: 16131836 [TBL] [Abstract][Full Text] [Related]
6. Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells. Yang SM; Li SY; Yu HB; Li JR; Sun LL Biomed Pharmacother; 2017 Jun; 90():93-99. PubMed ID: 28343076 [TBL] [Abstract][Full Text] [Related]
7. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer. Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960 [TBL] [Abstract][Full Text] [Related]
9. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A. Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop. Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas. Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide prevents ethanol-induced ZO-1 CpG promoter hypermethylation-dependent vascular permeability via miR-218/DNMT3a axis. Behera J; Kelly KE; Tyagi N J Cell Physiol; 2021 Oct; 236(10):6852-6867. PubMed ID: 33855696 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947 [TBL] [Abstract][Full Text] [Related]
14. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Hervouet E; Vallette FM; Cartron PF Epigenetics; 2009 Oct; 4(7):487-99. PubMed ID: 19786833 [TBL] [Abstract][Full Text] [Related]
15. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells. Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Rivenbark AG; Stolzenburg S; Beltran AS; Yuan X; Rots MG; Strahl BD; Blancafort P Epigenetics; 2012 Apr; 7(4):350-60. PubMed ID: 22419067 [TBL] [Abstract][Full Text] [Related]
17. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731 [TBL] [Abstract][Full Text] [Related]
18. Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. Medina-Aguilar R; Pérez-Plasencia C; Marchat LA; Gariglio P; García Mena J; Rodríguez Cuevas S; Ruíz-García E; Astudillo-de la Vega H; Hernández Juárez J; Flores-Pérez A; López-Camarillo C PLoS One; 2016; 11(6):e0157866. PubMed ID: 27355345 [TBL] [Abstract][Full Text] [Related]
19. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing. Yang Y; Liu R; Qiu R; Zheng Y; Huang W; Hu H; Ji Q; He H; Shang Y; Gong Y; Wang Y Oncogene; 2015 Jan; 34(1):104-18. PubMed ID: 24292684 [TBL] [Abstract][Full Text] [Related]
20. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]